Emergence of Azole-Resistant Strains due to Agricultural Azole Use Creates an Increasing Threat to Human Health

1. BrownGD, DenningDW, GowNA, LevitzSM, NeteaMG, et al. (2012) Hidden killers: human fungal infections. Sci Transl Med 4: 165rv13.

2. DenningD, PleuvryA, ColeD (2013) Global burden of ABPA in adults with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol 51: 361–370.

3. Lass-FlörlC (2011) Triazole antifungal agents in invasive fungal infections: a comparative review. Drugs 71: 2405–2419.

4. Van der Linden JWM, Arendrup MC, Verweij PE, SCARE network (2011) Prospective international surveillance of azole resistance in Aspergillus fumigatus: SCARE-Network. In: 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); Sep 17–20; Chicago, IL. Abstract M-490. (SCARE-NETWORK).

5. PfallerMA, BoykenL, HollisR, KroegerJ, MesserS, et al. (2011) Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Aspergillus species to the triazoles. J Clin Microbiol 49: 586–590.

6. Krishnan-Natesan S, Swaminathan S, Cutright J, et al.. (2010) Antifungal susceptibility pattern of Aspergillus fumigatus isolated from clinical specimens in Detroit Medical Center (DMC): rising frequency of high MIC of azoles (2003–2006). In: The 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); Sep 12–15; Boston, MA, USA.

7. ChowdharyA, KathuriaS, RandhawaHS, GaurSN, KlaassenCH, et al. (2012) Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India. J Antimicrob Chemother 67: 362–366.

8. SeyedmousaviS, HashemiSJ, ZibafarE, ZollJ, HedayatiMT, et al. (2013) Azole-resistant Aspergillus fumigatus, Iran. Emerg Infect Dis 19: 832–834.

9. LockhartSR, FradeJP, EtienneKA, PfallerMA, DiekemaDJ, et al. (2011) Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene. Antimicrob Agents Chemother 55: 4465–4468.

10. BowyerP, MooreCB, RautemaaR, DenningDW, RichardsonMD (2011) Azole antifungal resistance today: focus on Aspergillus. Curr Infect Dis Rep 13: 485–491.

11. SneldersE, van der LeeHAL, KuijpersJ, RijsAJMM, VargaJ, et al. (2008) Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 5: e219 doi:10.1371/journal.pmed.0050219

12. Van der LindenJWM, SneldersE, KampingaGA, RijndersBJA, MattssonE, et al. (2011) Clinical implications of azole resistance in Aspergillus fumigatus, the Netherlands, 2007–2009. Emerg Infect Dis 17: 1846–1852.

13. HowardSJ, CerarD, AndersonMJ, AlbarragA, FisherMC, et al. (2009) Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 15: 1068–1076.

14. ArendrupMC, MavridouE, MortensenKL, SneldersE, Frimodt-MøllerN, et al. (2010) Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence. PLoS ONE 5: e10080 doi:10.1371/journal.pone.0010080

15. SneldersE, KarawajczykA, VerhoevenRJA, VenselaarH, SchaftenaarG, et al. (2011) The structure–function relationship of the Aspergillus fumigatus cyp51A L98H conversion by site-directed mutagenesis: the mechanism of L98H azole resistance. Fungal Genet Biol 48: 1062–1070.

16. FraczekMG, BromleyM, BuiedA, MooreCB, RajendranR, et al. (2013) The cdr1B efflux transporter is associated with non-cyp51A mediated itraconazole resistance in Aspergillus fumigatus. J Antimicrob Chemother 68: 1486–1496.

17. MelladoE, Garcia-EffronG, Alcazar-FuoliL, MelchersWJ, VerweijPE, et al. (2007) A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob Agents Chemother 51: 1897–904.

18. SneldersE, Karawajczyk, SchaftenaarG, VerweijPE, MelchersWJ (2010) Azole resistance profile of amino acid changes in Aspergillus fumigatus cyp51A based on protein homology modeling. Antimicrob Agents Chemother 54: 2425–2430.

19. SneldersE, Huis In 't VeldRA, RijsAJJM, KemaGHJ, MelchersWJ, et al. (2009) Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles. Appl Environ Microbiol 75: 4053–4057.

20. DenningDW, ParkS, Lass-FlörlC, FraczekMG, KirwanM, et al. (2011) High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis 52: 1123–1129.

21. ChowdharyA, KathuriaS, XuJ, SharmaC, SundarG, et al. (2012) Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR34/L98H mutations in the cyp51A gene in India. PLoS ONE 7: e52871 doi:10.1371/journal.pone.0052871

22. MortensenKL, MelladoE, Lass-FlörlC, Rodriguez-TudelaJL, JohansenHK, et al. (2010) Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain. Antimicrob Agents Chemother 54: 4545–4549.

23. BadaliH, VaeziA, HaghaniI, YazdanparastSA, HedayatiMT, et al. (2013) Environmental study of azole-resistant Aspergillus fumigatus with TR34/L98H mutations in the cyp51A gene in Iran. Mycoses doi:10.1111/myc.12089. In press

24. van der LindenJW, CampsSM, KampingaGA, ArendsJP, Debets-OssenkoppYJ, et al. (2013) Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domestic homes. Clin Infect Dis 57: 513–520.

25. VermeulenE, MaertensJ, SchoemansH, LagrouK (2012) Azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation emerging in Belgium, July 2012. Euro Surveill 17. pii: 20326.

26. ChowdharyA, SharmaC, KathuriaS, HagenF, MeisJF (2013) Azole-resistant Aspergillus fumigatus with the environmental TR46/Y121F/T289A mutation in India. J Antimicrob Chemother doi:10.1093/jac/dkt397. In press

27. VerweijPE, KemaGH, ZwaanB, MelchersWJ (2013) Triazole fungicides and the selection of resistance to medical triazoles in the opportunistic mould Aspergillus fumigatus. Pest Manag Sci 69: 165–170.

28. SerflingA, WohlrabJ, DeisingHB (2007) Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy. Antimicrob Agents Chemother 51: 3672–3676.

29. SneldersE, CampsSMT, KarawajczykA, SchaftenaarG, KemaGHJ, et al. (2012) Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus. PLoS ONE 7: e31801 doi:10.1371/journal.pone.0031801

30. KlaassenCH, GibbonsJG, FedorovaND, MeisJF, RokasA (2012) Evidence for genetic differentiation and variable recombination rates among Dutch populations of the opportunistic human pathogen Aspergillus fumigatus. Mol Ecol 21: 57–70.

31. MavridouE, MeletiadisJ, JancuraP, AbbasS, ArendrupMC, et al. (2013) Composite survival index to compare virulence changes in azole-resistant Aspergillus fumigatus clinical isolates. PLoS ONE 8: e72280 doi:10.1371/journal.pone.0072280

32. Vale-Silva, CosteAT, IscherF, ParkerJE, KellySL, et al. (2012) Azole resistance by loss of function of the sterol Δ5,6- desaturase gene (ERG3) in Candida albicans does not necessarily decrease virulence. Antimicrob Agents Chemother 56: 1960–1968.

33. CampsSMT, DutilhBE, ArendrupMC, RijsAJMM, SneldersE, et al. (2012) Discovery of a hapE mutation that causes azole resistance in Aspergillus fumigatus through whole genome sequencing and sexual crossing. PLoS ONE 7: e50034 doi:10.1371/journal.pone.0050034